Plain-English translation of NCT06847126 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether oral Cefixime plus metronidazole works as well as intravenous (injected) antibiotics for treating liver abscess, a serious infection inside the liver. Right now, doctors often use IV antibiotics as the standard treatment, but there is limited evidence that they work better than oral antibiotics. This study wants to find out if taking pills instead could be just as effective, safer, and easier for patients.
Most doctors currently prefer giving IV antibiotics for liver abscess, but there is no strong clinical evidence proving this is better than oral antibiotics. If oral medication works just as well, it could reduce hospital stays, lower costs, reduce the risk of hospital-related infections, and help prevent antibiotic resistance.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either IV antibiotics for 2 weeks or oral antibiotic pills for 2 weeks, along with standard care (which may include draining the abscess if needed). Both groups also receive metronidazole (another antibiotic) to cover against all possible causes of the infection. The study lasts 2 weeks, and researchers will monitor your recovery to see which treatment approach works better.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
India